Predictors of ST Depression Resolution in STEMI Patients Undergoing Primary PCI and Its Clinical Significance.

ST depression resolution ST elevation resolution major adverse cardiac events primary percutaneous intervention

Journal

International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487

Informations de publication

Date de publication:
2020
Historique:
received: 17 04 2020
accepted: 28 05 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 2 7 2020
Statut: epublish

Résumé

ST depression resolution (STD-R) in ECG is a prognostic factor indicative of successful fibrinolysis or angioplasty in the treatment of ST elevation myocardial infarction (STEMI) and subsequent mortality. We conducted this study to determine the clinical significance of STD-R and its predictors in patients with anterior STEMI undergoing primary percutaneous intervention (PPCI). Admission documents of all patients with diagnosis of anterior STEMI who were admitted to a specialty heart center and underwent PPCI since July 2018 until July 2019 were examined. The amount of ST elevation and depression in all 12 leads of a standard ECG at admission and 90 minutes after PPCI was measured and resolution was determined. All patients were followed-up for 10.8±4.0 months. A total of 179 patients had ST depression besides elevation in the first ECG. Female gender, diabetes, not smoking, lower hemoglobin, and higher platelet counts were significantly more common in the group with less than 50% resolution of ST depression. STD-R <50% was significantly associated with the incidence of in-hospital acute heart failure and major adverse cardiac events (MACE) (p value: 0.025 and 0.012, respectively) and resolution of ST elevation ≥50% was associated with reduced in-hospital mortality (p value <0.0001). According to Kaplan-Meier curve, survival in the two groups of STE-R ≥50% and STE-R <50% was significantly different (Log rank: 31.18, p value<0.0001). STD-R can be considered to have high predictive power, like STE-R for predicting incidence of in-hospital acute heart failure and major adverse cardiac events.

Identifiants

pubmed: 32606891
doi: 10.2147/IJGM.S258573
pii: 258573
pmc: PMC7292485
doi:

Types de publication

Journal Article

Langues

eng

Pagination

271-279

Informations de copyright

© 2020 Ghaffari et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Heart. 2015 Nov;101(22):1819-25
pubmed: 26385452
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
J Am Coll Cardiol. 1984 Jul;4(1):28-34
pubmed: 6330194
J Am Coll Cardiol. 1984 Sep;4(3):467-76
pubmed: 6470325
J Am Coll Cardiol. 1997 Nov 15;30(6):1478-83
pubmed: 9362405
Eur Heart J. 2010 Mar;31(5):573-81
pubmed: 19952006
J Am Coll Cardiol. 1983 Aug;2(2):251-7
pubmed: 6863761
Am J Cardiol. 2005 Jan 15;95(2):234-6
pubmed: 15642556
Am Heart J. 2010 Nov;160(5):842-848.e1-2
pubmed: 21095270
Am Heart J. 1986 Dec;112(6):1210-6
pubmed: 3788768
Glob Heart. 2012 Dec;7(4):275-95
pubmed: 25689940
Int J Cardiol. 2015 Mar 1;182:232-4
pubmed: 25577769
J Am Coll Cardiol. 2004 Aug 4;44(3):671-719
pubmed: 15358045
Am J Cardiol. 1985 Jul 1;56(1):23-6
pubmed: 4014035
J Am Coll Cardiol. 1994 Aug;24(2):384-91
pubmed: 8034872
Circ J. 2007 Dec;71(12):1851-6
pubmed: 18037735
J Electrocardiol. 2018 May - Jun;51(3):524-530
pubmed: 29331309

Auteurs

Samad Ghaffari (S)

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Kasra Kolahdouzan (K)

Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Mehran Rahimi (M)

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Arezou Tajlil (A)

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Classifications MeSH